Committed to Medical Innovations
Every day—in research labs across eastern Massachusetts—investigators, doctors and nurses at Partners HealthCare are working to discover new treatment options, medical devices and technology to improve the lives and outcomes of patients. Partners HealthCare Innovation works directly with researchers at Brigham and Women’s Hospital, Massachusetts General Hospital, McLean Hospital and Spaulding Hospital to commercialize their innovations. It is our mission to enable commercialization through the best route for a given technology, and ensure that technologies can benefit patients.
RaNA Therapeutics today announced the company has relaunched as Translate Bio. Translate Bio is a leading biotechnology company pioneering the translation of RNA science into therapeutics promoting healthy gene expression in people living with debilitating genetic diseases.Read More
PARTNERS INNOVATION DEVELOPMENT GRANTS PROGRAM Program Guidelines – 2018 Program Cycle BACKGROUND AND PURPOSE The Innovation Discovery Grants (IDG) program aims to enhance the commercial outcomes of the Partners HealthCare community and to increase its innovative potential. It is designed to stimulate new inventive concepts, identify areas of commercially significant scientific strength, and accelerate commercialization…Read More
The 2018 World Medical Innovation Forum focuses on the advancements and opportunities of Artificial Intelligence. The event will bring together industry-leading CEOs, Partners' HIT experts, investors and deal makers to share perspectives on how cognitive computation, machine learning, and big date are having a transformative impact on patient care.